Approval Status: Approved September 1997
Treatment for: AIDS, HIV Infection
Areas: Immune System
The U.S. Food and Drug Administration approved the first one-pill combination of the two most widely used antiretroviral medications for AIDS and HIV infection. Combivir, a combination of Retrovir (zidovudine or AZT) and Epivir (lamivudine or 3TC), could decrease the number of pills people with HIV have to take daily.
Side effects include: nausea, diarrhea, anemia, low white blood cells, pancreatitis and neuropathy.
Combivir Drug Information
The Combivir drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.